307 related articles for article (PubMed ID: 19262227)
1. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
[TBL] [Abstract][Full Text] [Related]
2. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
Fiebeler A; Nussberger J; Shagdarsuren E; Rong S; Hilfenhaus G; Al-Saadi N; Dechend R; Wellner M; Meiners S; Maser-Gluth C; Jeng AY; Webb RL; Luft FC; Muller DN
Circulation; 2005 Jun; 111(23):3087-94. PubMed ID: 15939810
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.
Mervaala E; Müller DN; Park JK; Dechend R; Schmidt F; Fiebeler A; Bieringer M; Breu V; Ganten D; Haller H; Luft FC
Hypertension; 2000 Jan; 35(1 Pt 2):360-6. PubMed ID: 10642325
[TBL] [Abstract][Full Text] [Related]
6. Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.
Muller DN; Mervaala EM; Schmidt F; Park JK; Dechend R; Genersch E; Breu V; Löffler BM; Ganten D; Schneider W; Haller H; Luft FC
Hypertension; 2000 Aug; 36(2):282-90. PubMed ID: 10948091
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
Die J; Wang K; Fan L; Jiang Y; Shi Z
Brain Res; 2010 Jul; 1346():251-61. PubMed ID: 20513366
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
[TBL] [Abstract][Full Text] [Related]
10. Complement activation in angiotensin II-induced organ damage.
Shagdarsuren E; Wellner M; Braesen JH; Park JK; Fiebeler A; Henke N; Dechend R; Gratze P; Luft FC; Muller DN
Circ Res; 2005 Sep; 97(7):716-24. PubMed ID: 16109917
[TBL] [Abstract][Full Text] [Related]
11. Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
Theuer J; Shagdarsuren E; Muller DN; Kaergel E; Honeck H; Park JK; Fiebeler A; Dechend R; Haller H; Luft FC; Schunck WH
Kidney Int; 2005 Jan; 67(1):248-58. PubMed ID: 15610248
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
Kang BY; Mehta JL
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
[TBL] [Abstract][Full Text] [Related]
13. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
van der Harst P; Groenewegen HC; Roks AJ; Buikema H; Zijlstra F; van Gilst WH; de Smet BJ
Coron Artery Dis; 2008 Feb; 19(1):47-53. PubMed ID: 18281816
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
Whaley-Connell A; Habibi J; Nistala R; Cooper SA; Karuparthi PR; Hayden MR; Rehmer N; DeMarco VG; Andresen BT; Wei Y; Ferrario C; Sowers JR
Hypertension; 2008 Feb; 51(2):474-80. PubMed ID: 18172055
[TBL] [Abstract][Full Text] [Related]
16. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
Bulhak AA; Gourine AV; Gonon AT; Sjöquist PO; Valen G; Pernow J
Acta Physiol Scand; 2005 Feb; 183(2):151-9. PubMed ID: 15676056
[TBL] [Abstract][Full Text] [Related]
17. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
[TBL] [Abstract][Full Text] [Related]
18. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
[TBL] [Abstract][Full Text] [Related]
19. Entacapone protects from angiotensin II-induced inflammation and renal injury.
Helkamaa T; Finckenberg P; Louhelainen M; Merasto S; Rauhala P; Lapatto R; Cheng ZJ; Reenilä I; Männistö P; Müller DN; Luft FC; Mervaala EM
J Hypertens; 2003 Dec; 21(12):2353-63. PubMed ID: 14654757
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats.
Neto-Ferreira R; Novaes Rocha V; da Silva Torres T; Mandarim-de-Lacerda CA; de Carvalho JJ
Exp Toxicol Pathol; 2011 Jul; 63(5):473-8. PubMed ID: 20537513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
